Sai Life Sciences Limited is an India-based contract research, development, and manufacturing organization (CRO/CDMO). The Company carries out contract research and manufacturing activities for customers engaged in pharmaceutical and biotechnology industries. It is engaged in offering a range of services tailor-made to the customer's requirements. It provides discovery and chemistry, manufacturing, and controls (CMC) services that span from drug discovery to process development and early-phase supplies, all the way to commercial launch and life cycle management. Its services include Integrated Drug Discovery, Synthetic & medicinal chemistry, Biology, drug metabolism and pharmacokinetics (DMPK), Genotoxicity, General Toxicology and Computational chemistry. Its CMC services include route scouting; process development; analytical development; process safety; stability studies; early and mid-phase supplies; late phase, commercial manufacturing; technology transfer, and technologies.As of 25 May 2026, SAI LIFE SCIENCES LIMITED share price is ₹1,175.90. The stock opened at ₹1,116.90, compared to its previous close of ₹1,113.80. During today's trading session, SAI LIFE SCIENCES LIMITED share price moved in the range of ₹1,108.50 to ₹1,184.80, with an average price of ₹1,146.65 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,108.50 and a high of ₹1,184.80. On the performance front, SAI LIFE SCIENCES LIMITED share price has increased by 34.44% over the last six months and is up 63.50% on a year-on-year basis.
The market capitalization of SAI LIFE SCIENCES LIMITED is ₹23,601 Crs, with a P/E ratio of 67.6 and a dividend yield of 0.00%.